Cancer waiting times: patients starting treatment not via the urgent suspected cancer pathway, October 2009 to November 2020

Contents

View options

Filters

Data description ( of 3 selected3 selectable options)

Select all Data description|Select None of Data description

Date ( of 134 selected134 selectable options)

Select all Date|Select None of Date

local health board ( of 9 selected9 selectable options)

Select all local health board|Select None of local health board
Select all Wales|Select None of Wales

tumour site ( of 15 selected15 selectable options)

Select all tumour site|Select None of tumour site
Select all Total|Select None of Total

Data valuesData descriptionDatelocal health boardtumour site
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesSarcoma
95.9Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesSkin
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesBrain/Central Nervous System
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesBreast
93.3Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesGynaecological
91.7Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesUrological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesHaematological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesAcute Leukaemia
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesChildren's cancer
96.3Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020WalesOther
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardTotal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardHead and neck
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardUpper Gastrointestinal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardLower Gastrointestinal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardLung
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardSarcoma
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardSkin
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardBrain/Central Nervous System
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardBreast
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardGynaecological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardUrological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardHaematological
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardAcute Leukaemia
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardChildren's cancer
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Betsi Cadwaladr University Health BoardOther
98.9Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardTotal
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardHead and neck
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardUpper Gastrointestinal
87.5Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardLower Gastrointestinal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardLung
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardSarcoma
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardSkin
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardBrain/Central Nervous System
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardBreast
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardGynaecological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardUrological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardHaematological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardAcute Leukaemia
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardChildren's cancer
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Hywel Dda University Health BoardOther
94.2Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardTotal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardHead and neck
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardUpper Gastrointestinal
92.3Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardLower Gastrointestinal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardLung
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardSarcoma
83.3Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardSkin
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardBrain/Central Nervous System
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardBreast
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardGynaecological
87.5Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardUrological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardHaematological
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardAcute Leukaemia
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardChildren's cancer
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Swansea Bay University Health BoardOther
94.1Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardTotal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardHead and neck
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardUpper Gastrointestinal
93.8Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardLower Gastrointestinal
90.5Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardLung
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardSarcoma
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardSkin
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardBrain/Central Nervous System
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardBreast
75.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardGynaecological
88.2Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardUrological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardHaematological
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardAcute Leukaemia
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardChildren's cancer
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cwm Taf Morgannwg University Health BoardOther
88.3Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardTotal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardHead and neck
66.7Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardUpper Gastrointestinal
66.7Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardLower Gastrointestinal
95.7Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardLung
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardSarcoma
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardSkin
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardBrain/Central Nervous System
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardBreast
87.5Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardGynaecological
83.9Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardUrological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardHaematological
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardAcute Leukaemia
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardChildren's cancer
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Aneurin Bevan University Health BoardOther
85.6Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardTotal
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardHead and neck
90.9Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardUpper Gastrointestinal
60.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardLower Gastrointestinal
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardLung
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardSarcoma
83.3Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardSkin
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardBrain/Central Nervous System
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardBreast
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardGynaecological
85.7Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardUrological
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardHaematological
0.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardAcute Leukaemia
100.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardChildren's cancer
75.0Percentage of patients starting treatment not via the urgent cancer pathway within 31 daysSeptember 2020Cardiff and Vale University Health BoardOther
Showing 41,901 to 42,000 of 42,210 rows
Page 420 of 423

Main information

Most recent update
26 September 2025
Next update expected
This dataset is not expected to be updated or replaced in the future
Designation
Accredited official statistics
Data provider
NHS Trusts and Local Health Boards
Data source
No specific source from data provider

Data notes

Rounding applied

The 'percentage starting treatment within 62 days' has been rounded to one decimal place.

Overview

Summary of dataset and variables

Historical information on cancer waiting times, reported by local health boards, for those patients newly diagnosed with cancer who have started definitive treatment during the month.

Data collection or calculation

From February 2021, data is only published for the suspected cancer pathway. Targets for the urgent and not via the urgent pathway have ceased and no new data will be collected or published for these pathways. The patients shown here are those treated via the non urgent route. The national target for these patients is: at least 98 per cent of patients newly diagnosed with cancer, not via the urgent route will start definitive treatment within 31 days of diagnosis (regardless of the referral route). Care should be taken when interpreting percentages, especially when dealing with small numbers.

Statistical quality

Please find this information in the related statistical release, as per the given weblink.

Related reports

Published by

Organisation
Welsh Government
Contact email
stats.healthinfo@gov.wales

Select the filtered or whole dataset to download

Select download format

Contains only the dataset
Contains only the dataset
Contains only the dataset

Select number formatting

This includes rounding to decimal places and commas to separate thousands
This includes rounding to decimal places and commas to separate thousands

Select language

Metadata

The metadata for this dataset is not included when you download the data. You can download this separately. This contains all the information from the 'About this dataset' tab.

Download metadata